Limits to potent antiretroviral therapy

Area of Science:

• Virology
• Immunology
• Pharmacology

Background:

• Combination antiretroviral therapy (ART), or highly active antiretroviral therapy (HAART), has significantly altered the outlook for individuals with HIV infection.
• Despite advancements, current ART strategies face challenges including incomplete viral eradication and suboptimal immune system recovery.
• High rates of drug resistance and potential long-term toxicities are significant concerns associated with existing treatments.

Purpose of the Study:

• To evaluate the current state of antiretroviral therapy for HIV infection.
• To identify the limitations and deficiencies of existing potent combination antiretroviral therapy (ART).
• To propose the need for refined treatment strategies for HIV-infected patients.

Main Methods:

• Review of current literature on antiretroviral therapy (ART) for HIV.
• Analysis of the efficacy and limitations of highly active antiretroviral therapy (HAART).
• Assessment of viral resistance, immune recovery, and long-term toxicity associated with ART.

Main Results:

• ART has transformed HIV prognosis but does not achieve complete viral eradication.
• Immune system recovery can be slow and incomplete in patients on ART.
• Significant challenges include the high prevalence of drug resistance and potential long-term side effects.

Conclusions:

• Current antiretroviral therapy (ART) for HIV, while effective, has inherent limitations.
• Future treatment strategies must address the failure to eradicate the virus, immune reconstitution issues, resistance, and toxicity.
• Optimizing treatment requires careful consideration of these factors to best target HIV-infected patients.